ID   MAPK3_HUMAN             Reviewed;         382 AA.
AC   Q16644; B5BU67;
DT   06-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   05-OCT-2010, entry version 89.
DE   RecName: Full=MAP kinase-activated protein kinase 3;
DE            Short=MAPK-activated protein kinase 3;
DE            Short=MAPKAP kinase 3;
DE            Short=MAPKAPK-3;
DE            EC=2.7.11.1;
DE   AltName: Full=Chromosome 3p kinase;
DE            Short=3pK;
GN   Name=MAPKAPK3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   PHOSPHORYLATION.
RX   MEDLINE=96215257; PubMed=8626550; DOI=10.1074/jbc.271.14.8488;
RA   McLaughlin M.M., Kumar S., McDonnell P.C., Van Horn S., Lee J.C.,
RA   Livi G.P., Young P.R.;
RT   "Identification of mitogen-activated protein (MAP) kinase-activated
RT   protein kinase-3, a novel substrate of CSBP p38 MAP kinase.";
RL   J. Biol. Chem. 271:8488-8492(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND PHOSPHORYLATION.
RC   TISSUE=Heart;
RX   MEDLINE=96182089; PubMed=8622688;
RA   Sithanandam G., Latif F., Duh F.-M., Bernal R., Smola U., Li H.,
RA   Kuzmin I., Wixler V., Geil L., Shrestha S., Lloyd P.A., Bader S.,
RA   Sekido Y., Tartof K.D., Kashuba V.I., Zabarovsky E.R., Dean M.,
RA   Klein G., Lerman M.I., Minna J.D., Rapp U.R., Allikmets R.;
RT   "3pK, a new mitogen-activated protein kinase-activated protein kinase
RT   located in the small cell lung cancer tumor suppressor gene region.";
RL   Mol. Cell. Biol. 16:868-876(1996).
RN   [3]
RP   ERRATUM.
RA   Sithanandam G., Latif F., Duh F.-M., Bernal R., Smola U., Li H.,
RA   Kuzmin I., Wixler V., Geil L., Shrestha S., Lloyd P.A., Bader S.,
RA   Sekido Y., Tartof K.D., Kashuba V.I., Zabarovsky E.R., Dean M.,
RA   Klein G., Lerman M.I., Minna J.D., Rapp U.R., Allikmets R.;
RL   Mol. Cell. Biol. 16:1880-1880(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=19054851; DOI=10.1038/nmeth.1273;
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H.,
RA   Maruyama Y., Matsuo K., Minami K., Mitsubori M., Mori M.,
RA   Morishita R., Murase A., Nishikawa A., Nishikawa S., Okamoto T.,
RA   Sakagami N., Sakamoto Y., Sasaki Y., Seki T., Sono S., Sugiyama A.,
RA   Sumiya T., Takayama T., Takayama Y., Takeda H., Togashi T., Yahata K.,
RA   Yamada H., Yanagisawa Y., Endo Y., Imamoto F., Kisu Y., Tanaka S.,
RA   Isogai T., Imai J., Watanabe S., Nomura N.;
RT   "Human protein factory for converting the transcriptome into an in
RT   vitro-expressed proteome.";
RL   Nat. Methods 5:1011-1017(2008).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH TCF3.
RX   PubMed=10781029; DOI=10.1074/jbc.C901040199;
RA   Neufeld B., Grosse-Wilde A., Hoffmeyer A., Jordan B.W., Chen P.,
RA   Dinev D., Ludwig S., Rapp U.R.;
RT   "Serine/Threonine kinases 3pK and MAPK-activated protein kinase 2
RT   interact with the basic helix-loop-helix transcription factor E47 and
RT   repress its transcriptional activity.";
RL   J. Biol. Chem. 275:20239-20242(2000).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15302577; DOI=10.1016/j.yexcr.2004.05.027;
RA   Zakowski V., Keramas G., Kilian K., Rapp U.R., Ludwig S.;
RT   "Mitogen-activated 3p kinase is active in the nucleus.";
RL   Exp. Cell Res. 299:101-109(2004).
RN   [9]
RP   FUNCTION, MUTAGENESIS OF LYS-73, AND INTERACTION WITH PHC2 AND BMI1.
RX   PubMed=15563468; DOI=10.1074/jbc.M407155200;
RA   Voncken J.W., Niessen H., Neufeld B., Rennefahrt U., Dahlmans V.,
RA   Kubben N., Holzer B., Ludwig S., Rapp U.R.;
RT   "MAPKAP kinase 3pK phosphorylates and regulates chromatin association
RT   of the polycomb group protein Bmi1.";
RL   J. Biol. Chem. 280:5178-5187(2005).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-28; ALA-105 AND TYR-276.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Modulator of polycomb-mediated repression, which can be
CC       activated either by ERK, p38 and JNK. Substrate of CSBP. In vitro,
CC       phosphorylates HSPB1, BMI1/PCGF4 and TCF3.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: Interacts with TCF3 and with polycomb proteins, such as
CC       PCH2 and BMI1/PCGF4.
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Predominantly
CC       located in the nucleus, when activated it translocates to the
CC       cytoplasm.
CC   -!- TISSUE SPECIFICITY: Widely expressed, with a higher expression
CC       level observed in heart and skeletal muscle. No expression in
CC       brain.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U43784; AAC50428.1; -; mRNA.
DR   EMBL; U09578; AAD09136.1; -; mRNA.
DR   EMBL; AB451303; BAG70117.1; -; mRNA.
DR   EMBL; CH471055; EAW65131.1; -; Genomic_DNA.
DR   EMBL; BC001662; AAH01662.1; -; mRNA.
DR   EMBL; BC007591; AAH07591.1; -; mRNA.
DR   EMBL; BC010407; AAH10407.1; -; mRNA.
DR   IPI; IPI00005777; -.
DR   PIR; JC6094; JC6094.
DR   RefSeq; NP_004626.1; -.
DR   UniGene; Hs.234521; -.
DR   PDB; 3FHR; X-ray; 1.90 A; A=33-349.
DR   PDB; 3FXW; X-ray; 2.00 A; A=33-349.
DR   PDBsum; 3FHR; -.
DR   PDBsum; 3FXW; -.
DR   ProteinModelPortal; Q16644; -.
DR   SMR; Q16644; 35-368.
DR   STRING; Q16644; -.
DR   PhosphoSite; Q16644; -.
DR   PeptideAtlas; Q16644; -.
DR   PRIDE; Q16644; -.
DR   Ensembl; ENST00000357955; ENSP00000350639; ENSG00000114738.
DR   Ensembl; ENST00000446044; ENSP00000396467; ENSG00000114738.
DR   GeneID; 7867; -.
DR   KEGG; hsa:7867; -.
DR   UCSC; uc003day.1; human.
DR   CTD; 7867; -.
DR   GeneCards; GC03P050624; -.
DR   H-InvDB; HIX0003305; -.
DR   HGNC; HGNC:6888; MAPKAPK3.
DR   MIM; 602130; gene.
DR   PharmGKB; PA30632; -.
DR   eggNOG; prNOG16541; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG106948; -.
DR   InParanoid; Q16644; -.
DR   OMA; IRMGQYG; -.
DR   OrthoDB; EOG96DPN7; -.
DR   PhylomeDB; Q16644; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; p38_mk2pathway; p38 signaling mediated by MAPKAP kinases.
DR   Pathway_Interaction_DB; p38alphabetadownstreampathway; Signaling mediated by p38-alpha and p38-beta.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_6900; Signaling in Immune system.
DR   NextBio; 30313; -.
DR   ArrayExpress; Q16644; -.
DR   Bgee; Q16644; -.
DR   CleanEx; HS_MAPKAPK3; -.
DR   Genevestigator; Q16644; -.
DR   GermOnline; ENSG00000114738; Homo sapiens.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004708; F:MAP kinase kinase activity; TAS:ProtInc.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0007265; P:Ras protein signal transduction; EXP:Reactome.
DR   GO; GO:0006950; P:response to stress; TAS:ProtInc.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR020646; MAP_kin-act_prot_kinase.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF22; MAP_kin-act_prot_kinase; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Cytoplasm;
KW   Kinase; Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    382       MAP kinase-activated protein kinase 3.
FT                                /FTId=PRO_0000086293.
FT   DOMAIN       44    304       Protein kinase.
FT   NP_BIND      50     58       ATP (By similarity).
FT   ACT_SITE    166    166       Proton acceptor (By similarity).
FT   BINDING      73     73       ATP (By similarity).
FT   MOD_RES       1      1       N-acetylmethionine.
FT   VARIANT      28     28       P -> S (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040755.
FT   VARIANT     105    105       E -> A (in an ovarian endometrioid
FT                                sample; somatic mutation).
FT                                /FTId=VAR_040756.
FT   VARIANT     276    276       D -> Y (in dbSNP:rs56107897).
FT                                /FTId=VAR_040757.
FT   MUTAGEN      73     73       K->M: Higher affinity toward PCH2.
SQ   SEQUENCE   382 AA;  42987 MW;  405F958B7F54E6F3 CRC64;
     MDGETAEEQG GPVPPPVAPG GPGLGGAPGG RREPKKYAVT DDYQLSKQVL GLGVNGKVLE
     CFHRRTGQKC ALKLLYDSPK ARQEVDHHWQ ASGGPHIVCI LDVYENMHHG KRCLLIIMEC
     MEGGELFSRI QERGDQAFTE REAAEIMRDI GTAIQFLHSH NIAHRDVKPE NLLYTSKEKD
     AVLKLTDFGF AKETTQNALQ TPCYTPYYVA PEVLGPEKYD KSCDMWSLGV IMYILLCGFP
     PFYSNTGQAI SPGMKRRIRL GQYGFPNPEW SEVSEDAKQL IRLLLKTDPT ERLTITQFMN
     HPWINQSMVV PQTPLHTARV LQEDKDHWDE VKEEMTSALA TMRVDYDQVK IKDLKTSNNR
     LLNKRRKKQA GSSSASQGCN NQ
//
